Show Search Form
human indexable | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||
registered interest | |||||||||||||
answer date | |||||||||||||
date | |||||||||||||
date tabled | |||||||||||||
ddp created | |||||||||||||
answering body |
|
||||||||||||
question status | Tabled | ||||||||||||
answering dept id | 17 | ||||||||||||
answering dept short name | Health and Social Care | ||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||
ddp modified |
|
||||||||||||
hansard heading | Bacterial Diseases | ||||||||||||
house id | 2 | ||||||||||||
identifier | HL16692 | ||||||||||||
legislature |
|
||||||||||||
parliament number | 57 | ||||||||||||
question first answered |
|
||||||||||||
question text | To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 4 June (HL15832), what assessment they have made of (1) the future costs to the NHS as a result of the spread of carbapenem-resistant Enterobacteriaceae, (2) the costs of new measures introduced in 2019 specifically to prevent the transmission of such Enterobacteriaceae, and (3) the views of infection control nurses on investment to prevent the transmission of such Enterobacteriaceae. | ||||||||||||
session |
|
||||||||||||
session number | 1 | ||||||||||||
tabling member printed |
|
||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL16692 | ||||||||||||
type |
|
||||||||||||
uin | HL16692 | ||||||||||||
version | 1 | ||||||||||||
written parliamentary question type | Ordinary | ||||||||||||
answer | answer | ||||||||||||
creator |
|
||||||||||||
publisher | 25277 | ||||||||||||
tabling member | 3596 |